SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-003412
Filing Date
2024-01-12
Accepted
2024-01-12 16:51:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea191438-s3_adialpharma.htm S-3 375186
2 FORM OF INDENTURE ea191438ex4-3_adialpharma.htm EX-4.3 380247
3 OPINION OF BLANK ROME LLP ea191438ex5-1_adialpharma.htm EX-5.1 29306
4 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea191438ex23-1_adialpharma.htm EX-23.1 2346
5 CALCULATION OF FILING FEE TABLE ea191438ex-fee_adialpharma.htm EX-FILING FEES 19571
6 GRAPHIC image_001.jpg GRAPHIC 5664
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2395
  Complete submission text file 0001213900-24-003412.txt   819293
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276496 | Film No.: 24532623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)